Determining the optimal newborn screening protocol for cystic fibrosis

Thorax

Volumn 67, Issue 4, 2012, Pages 281-282

  Southern, Kevin W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PANCREATITIS ASSOCIATED PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

CFTR GENE; CFTR RELATED METABOLIC SYNDROME; CLINICAL PROTOCOL; COHORT ANALYSIS; CULTURAL ANTHROPOLOGY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DNA DETERMINATION; DNA SEQUENCE; EDITORIAL; EVIDENCE BASED PRACTICE; EXTENDED GENE ANALYSIS; FALSE NEGATIVE RESULT; GENE; GENE MUTATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; METABOLIC SYNDROME X; NEWBORN SCREENING; POPULATION DISTRIBUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL; SWEAT TEST; UNITED KINGDOM;

EID: 84858792013     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201589     Document Type: Editorial

References (16)

1. Southern KW, Merelle MM, Dankert-Roelse JE, et al. Newborn screening for cystic fibrosis. Cochrane Database Syst Rev 2009;(1):CD001402.
2. Farrell PM. Is newborn screening for cystic fibrosis a basic human right? J Cyst Fibros 2008;7:262-5.
3. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997;337:963-9. (Pubitemid 27425952)
4. Castellani C, Southern KW, Brownlee K, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009;8:153-73.
5. Comeau AM, Accurso FJ, White TB, et al. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics 2007;119:e495-518. (Pubitemid 46397760)
6. Tluczek A, Koscik RL, Farrell PM, et al. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics 2005;115:1692-703. (Pubitemid 43843181)
7. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979;1:472-4. (Pubitemid 9127240)
8. Southern KW, Munck A, Pollitt R, et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007;6:57-65. (Pubitemid 46029890)
9. Vernooij-van Langen AMM, Loeber JG, Elvers B, et al. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study. Thorax 2012;67:289-95.
10. Sarles J, Berthezene P, Le Louarn C, et al. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis. J Pediatr 2005;147:302-5. (Pubitemid 41345757)
11. Sommerburg O, Lindner M, Muckenthaler M, et al. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population. J Inherit Metab Dis 2010;33:S263-71.
12. Borowitz D, Parad RB, Sharp JK, et al. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009;155:S106-16.
13. McMahon VR, Schellenberg A, Burgess CA, et al. A novel approach to CF newborn screening: the optional sweat test [abstract]. Pediatr Pulmonol 2011;(Suppl 34):368-9.
14. Dijk FN, McKay K, Barzi F, et al. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre. Arch Dis Child 2011;96:1118-23.
15. Waters DL, Wilcken B, Irwing L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child 1999;80:F1-7. (Pubitemid 29129589)
16. McKay KO, Waters DL, Gaskin KJ. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. J Pediatr 2005;147(3 Suppl):S47-50. (Pubitemid 41400259)